HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Cristina Marchini Selected Research
Cristina Marchini Research Topics
Disease
24
Neoplasms (Cancer)
01/2022 - 05/2005
17
Breast Neoplasms (Breast Cancer)
01/2022 - 11/2010
7
Carcinogenesis
11/2020 - 04/2011
3
Carcinoma (Carcinomatosis)
01/2019 - 11/2010
2
Triple Negative Breast Neoplasms
01/2021 - 01/2016
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2020
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1
Adenocarcinoma
04/2011
1
Neoplasm Metastasis (Metastasis)
11/2010
1
Wounds and Injuries (Trauma)
11/2005
1
Alzheimer Disease (Alzheimer's Disease)
06/2002
Drug/Important Bio-Agent (IBA)
7
Proteins (Proteins, Gene)
FDA Link
01/2019 - 04/2010
5
DNA (Deoxyribonucleic Acid)
IBA
08/2021 - 06/2011
3
Gold
IBA
01/2022 - 07/2018
3
DNA Vaccines
IBA
12/2018 - 04/2010
2
Ruthenium
IBA
01/2021 - 01/2016
2
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 07/2018
2
Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)
IBA
11/2020 - 08/2014
2
phosphine (phosphane)
IBA
01/2020 - 07/2018
2
Phenobarbital (Luminal)
FDA Link
01/2020 - 01/2017
2
Biological Products
IBA
12/2019 - 01/2016
2
Protein Isoforms (Isoforms)
IBA
12/2018 - 10/2016
2
Resveratrol
IBA
01/2018 - 01/2017
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
10/2016 - 04/2010
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2022
1
Gold Compounds
IBA
01/2022
1
Lipid Nanoparticles
IBA
08/2021
1
imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)
IBA
01/2021
1
acetylshikonin
IBA
11/2020
1
human ERBB2 protein
IBA
11/2020
1
Caspase 3 (Caspase-3)
IBA
11/2020
1
Naphthoquinones
IBA
11/2020
1
MicroRNAs (MicroRNA)
IBA
01/2020
1
Epidermal Growth Factor (EGF)
IBA
01/2020
1
Biomarkers (Surrogate Marker)
IBA
01/2020
1
Azoles
IBA
01/2020
1
Ligands
IBA
01/2020
1
Nucleolin
IBA
12/2019
1
Messenger RNA (mRNA)
IBA
12/2019
1
Glu Transfer RNA
IBA
12/2019
1
ErbB Receptors (EGF Receptor)
IBA
12/2019
1
Stathmin
IBA
01/2019
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
07/2018
1
Deubiquitinating Enzymes
IBA
07/2018
1
Fluorouracil (Carac)
FDA Link
Generic
10/2017
1
3,7,11,15- tetramethyl- 1,2,3- hexadecanetriol
IBA
10/2017
1
Pharmaceutical Preparations
IBA
10/2017
1
Solutions
IBA
10/2017
1
Phytoestrogens (Phytoestrogen)
IBA
01/2017
1
70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
IBA
01/2017
1
Drinking Water
IBA
01/2017
1
Carcinogens
IBA
01/2017
1
Proteasome Inhibitors
IBA
01/2017
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2017
1
saracatinib
IBA
10/2016
1
dacomitinib
IBA
10/2016
1
Lapatinib (GW572016)
FDA Link
10/2016
1
Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)
IBA
01/2016
1
Ruthenium Compounds
IBA
01/2016
1
Immunoglobulin A (IgA)
IBA
01/2016
1
Immunoglobulin G (IgG)
IBA
01/2016
1
4-cymene (p-cymene)
IBA
01/2016
1
Blood Proteins (Serum Proteins)
IBA
01/2016
1
polyacrylamide
IBA
01/2016
1
Liposomes (Liposome)
IBA
01/2016
1
Autoantibodies
IBA
01/2016
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2016
1
Organometallic Compounds
IBA
01/2016
1
Platinum
IBA
01/2016
1
liposomal amphotericin B
FDA Link
01/2016
1
Protein Corona
IBA
01/2016
1
Antigens
IBA
01/2015
1
sanguinarine
IBA
08/2014
1
Interleukins
IBA
06/2014
1
Perforin
IBA
06/2014
1
dorsomorphin
IBA
02/2014
1
Bone Morphogenetic Proteins (Bone Morphogenetic Protein)
IBA
02/2014
1
Epitopes
IBA
01/2013
1
Trastuzumab (Herceptin)
FDA Link
01/2013
1
Cancer Vaccines
IBA
01/2013
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
10/2012
1
Elements
IBA
10/2012
1
1,2- dioleoyloxy- 3- (trimethylammonium)propane
IBA
06/2011
1
Lipids
IBA
06/2011
1
Propane
IBA
06/2011
1
Oncogene Proteins (Oncogene Protein)
IBA
04/2011
1
src-Family Kinases
IBA
04/2011
1
Firefly Luciferases
IBA
04/2011
1
Luciferases
IBA
04/2011
1
Keratin-14 (Keratin 14)
IBA
11/2005
1
Contrast Media
IBA
05/2005
1
Purinergic Receptors (Receptors, Purine)
IBA
06/2002
1
Adenylyl Cyclases (Adenylyl Cyclase)
IBA
06/2002
1
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
06/2002
Therapy/Procedure
8
Therapeutics
01/2022 - 11/2010
3
Immunotherapy
08/2021 - 01/2013
1
Drug Therapy (Chemotherapy)
01/2021
1
Oral Administration
08/2014
1
Neoadjuvant Therapy
11/2010
1
Microbubbles
05/2005